Project 3: ACHIEVE- CHD

Conditions

• Coronary Heart Disease

Eligibility Criteria

Sex

ALL

Age

40 Years - 75 Years

Healthy Volunteers

Not accepted

Interventions

• PAL2 — BEHAVIORAL
  Low CVD risk participants (CAC \< 100) will be followed by their primary care provider accompanied by monthly contact with community health workers provided by ACHIEVE Greater who will screen participants for social determinants of health and implement the PAL2. PAL2 is defined as a community health worked based intervention to mitigate psychosocial and health equity barriers to optimize health promotion coupled with high blood pressure and lifestyle disease state education.
• CINEMA — OTHER
  High CVD risk participants (CAC ≥ 100) will be followed by specialists in the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA) at UHCMC. While they too will be assessed, by the CHW for SDOH and a plan developed to address them, this plan will be addressed by the usual resources available in the CINEMA clinic.

Study Details

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Project 2) and coronary heart disease (CHD, Project 3), which drive downstream lifespan inequality. All three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. All three projects will also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 3 of the ACHIEVE GREATER Center.

Key Dates

Start date

Aug 15, 2022

Status verified

Jun 2025

Primary completion

Jan 1, 2027

Completion

Jan 1, 2027

Study Design

Enrollment

500 participants (estimated)

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Arms

• Other: Low CVD risk
  PAL2
• Other: High CVD risk
  Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA)

Primary Outcome Measure

Triple Goal [ Time Frame: 12 months ]

Central Contacts

• Sanjay Rajagopalan, MD
  216-844-5191
  [email protected]
• Heidi Osborne
  216-844-2833
  [email protected]

Locations (1)

Find similar trials in Cleveland, OH

Related Studies

• Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
  Recruiting · West Virginia School of Osteopathic Medicine · Lewisburg, West Virginia
• Thiamine Intervention and Coronary Artery Bypass Grafting
  EARLY_PHASE1 · Recruiting · University of California, Los Angeles · Los Angeles, California